Terminal modification on mPEG-dendritic poly-(l)-lysine cationic diblock copolymer for efficient gene delivery

Area of Science:

• Biomaterials Science
• Gene Therapy
• Nanotechnology

Background:

• Gene therapy requires efficient and safe non-viral vectors.
• Current vectors often face challenges with cytotoxicity and serum stability.

Purpose of the Study:

• To develop and characterize novel termini-modified mPEG-dendritic poly-(l)-lysine cationic diblock copolymers.
• To evaluate the potential of these copolymers as gene delivery vectors in vitro.

Main Methods:

• Synthesis and characterization of mPEG5k-DPL4-CG copolymers using (1)H NMR.
• Assessment of pDNA binding affinity via EB displacement and gel retardation assays.
• Evaluation of cytotoxicity and gene transfection efficiency in cell lines using luciferase assays.

Main Results:

• The mPEG5k-DPL4-PEI800 copolymer demonstrated high pDNA binding affinity and transfection efficiency.
• This vector exhibited low cytotoxicity and maintained efficiency in 10% FBS.
• Termini modification enhanced the gene delivery performance of the dendritic poly-(l)-lysine vector.

Conclusions:

• Termini-modified dendritic poly-(l)-lysine copolymers, particularly mPEG5k-DPL4-PEI800, are promising non-viral gene vectors.
• The developed vector shows potential for gene therapy due to its low cytotoxicity and serum resistance.
• This offers a potential long-circulating gene vector for therapeutic applications.